TrialContemporary clinical trials2022

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.

Erin K McCreary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.